Anti-Venom Market Research Report 2019 By Type (Polyvalent, Monovalent, Others), by Species (Snake, Others), by Mode of Action (Cytotoxic, Neurotoxic, Haemotoxic, Others), by Products (Snake Anti-Venom, Others), and by End-User – Global Forecast Till 2023
—
The global anti-venom market is predicted to grow at a 6.5% CAGR over the forecast period (2017-2023), as per the latest Market Research Future (MRFR) report.
Anti-Venom Market Analysis
Anti-venom, which is also known as anti-venom immunoglobulin, venom antiserum, and antivenin, is a medicine made from antibodies that is used for treating specific stings and venomous bites. This antibody product can help to disable the toxins of a venom. When injected quickly after a sting or a bite, the antibodies present in anti-venom will help in neutralizing the venom, thus potentially saving the limb or life of the victim.
Various factors are propelling the anti-venom market growth. These factors, as stated by the MRFR report, include rising incidence of snake bites, rising government funding for research and development activities, unmet medical needs, and increasing patient pool. Additional factors pushing market growth include increasing government assistance, enhancing regulatory framework, and growing awareness about anti-venoms.
Avail FREE Sample at https://www.marketresearchfuture.com/sample_request/5859
On the contrary, the soaring price of anti-venom due to high production cost in various regions, inappropriate clinical application, inconsistent quality standards, lack in availability of anti-venom stock, and inefficient production processes are factors that may restrict the anti-venom market growth over the forecast period.
Key Players
Leading players profiled in the anti-venom market report include
Boston Scientific Corporation
Novo Nordisk A/s
UltiMed Inc.
Terumo Corporation
Stryker Corporation
Smiths Medical
Roboz Surgical Instrument
Owen Mumford Ltd.
Allison Medical Inc.
Medtronic plc
Medline Industries Inc.
Johnson & Johnson Services Inc
Hu-Friedy Mfg. Co. LLC
cHill-Rom
Allison Medical Inc.
Dickinson and Company
Becton
Braun Melsungen AG
Artsana S.p.a.
Ypsomed Holding AG
Thermo Fisher Scientific
among others.
Market Segmentation
The Market Research Future report provides a wide segmental analysis of the anti-venom market based on end user, product type, mode of action, type of species, and type.
Based on type, the anti-venom market is segmented into small molecule anti-toxins, homologous anti-venom, monovalent heterologous anti-venom, and polyvalent heterologous anti-venom. Of these, the polyvalent heterologous anti-venom segment will have the largest share in the market over the forecast period.
Based on species type, the anti-venom market is segmented into spiders, scorpions, snakes, and others. The snake segment is further segmented into Russell Viper, common krait, common cobra, and others.
Based on the mode of action, the anti-venom market is segmented into myotoxic, cardiotoxic, haemotoxic, neurotoxic, cytotoxic, and others.
Based on product types, the anti-venom market is segmented into spider anti-venom, scorpion anti-venom, snake anti-venom, and others. Of these, the snake anti-venom segment will dominate the market over the forecast period.
Based on end user, the anti-venom market is segmented into surgical centers, ambulatory, clinics, hospitals, and others. Of these, the hospitals segment will lead the market over the forecast period.
Browse Complete Report Details at https://www.marketresearchfuture.com/reports/anti-venom-market-5859
Regional Analysis
Based on the region, the anti-venom market report covers the latest trends and growth opportunities across Europe, the Americas, Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will dominate the market over the forecast period. This is owing to the high healthcare expenditure and rising cases of scorpion and snake bites in the region.
The anti-venom market in Europe will have the second largest share in the market over the forecast period. This is owing to the improvements being made in the reimbursement scenario and strong financial support made by the government for R&D activities.
The anti-venom market in the APAC region is predicted to grow at the fastest pace over the forecast period. This is owing to the rising advancements in pharmaceuticals and the huge patient pool.
The anti-venom market in the Middle East and Africa is predicted to have the lowest share over the forecast period. This is owing to poor medical facilities, lack of technical know-how, and restricted economic development.
Ask for an Exclusive Discount on this Report at https://www.marketresearchfuture.com/check-discount/5859
July 2019: A research team in Bangladesh for the very first time is reviewing native snake species with an aim to offer local patients with an effective anti-venom at a mass scale production. The researchers will be collecting venoms from various snakes, analyzing their properties, and developing methods for producing the antidote.
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Market Research Future
+1 646 845 9312
Email: [email protected]
Contact Info:
Name: Mr. Akash Anand
Email: Send Email
Organization: Market Research Future
Address: Magarpatta Road, Hadapsar, Pune
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/anti-venom-market-5859
Source: MarketersMedia
Release ID: 88914731
